NOTES ON EAST AFRICAN PLANT VIRUS DISEASES. VI. VIRUS DISEASES OF PASSIFLORA IN KENYABAKKER W.1974; E. AFR. AGRIC. FOREST. J.; KENYA; DA. 1974; VOL. 40; NO 1; PP. 11-23; BIBL. 30REF.Article

COMPLICATIONS OF POSTOPERATIVE INTRAPLEURAL BCG IN LUNG CANCERBAKKER W; NIJHUIS HEDDES JMA.1982; ANN. THORAC. SURG.; ISSN 0003-4975; USA; DA. 1982; VOL. 33; NO 3; PP. 267-272; BIBL. 13 REF.Article

Variables affecting mixed oxidant corrosion of stainless steels in gasifiersBAKKER, W. T.Materials and corrosion (1995). 2000, Vol 51, Num 4, pp 219-223, issn 0947-5117Conference Paper

The origin of the S. Patris Ephraem Syri Sermo de Sanctissimae Dei Genitricis Virginis Mariae Laudibus (Assemani III: 575-577)BAKKER, W. F.Byzantion (Bruxelles). 2004, Vol 74, Num 1, pp 147-197, issn 0378-2506, 51 p.Article

A MATCHED-PAIR STUDY OF THE LEUKOCYTE ELASTASE-LIKE ACTIVITY IN NORMAL PERSONS AND IN EMPHYSEMATOUS PATIENTS WITH AND WITHOUT ALPHA₁-ANTITRYPSIN DEFICIENCYKRAMPS JA; BAKKER W; DIJKMAN JH et al.1980; AMER. REV. RESP. DIS.; USA; DA. 1980; VOL. 121; NO 2; PP. 253-261; BIBL. 40 REF.Article

Effect of gasifier environment on materials performanceBAKKER, W. T.Materials at high temperatures. 1993, Vol 11, Num 1-4, pp 81-89, issn 0960-3409Conference Paper

Materials for ultrasupercritical coal power plants-boiler materials : Part 1VISWANATHAN, R; BAKKER, W.Journal of materials engineering and performance. 2001, Vol 10, Num 1, pp 81-95, issn 1059-9495Article

Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment : clinical outcome, microbiology and pharmacokineticsVINKS, A. A. T. M. M; BRIMICOMBE, R. W; HEIJERMAN, H. G. M et al.Journal of antimicrobial chemotherapy (Print). 1997, Vol 40, Num 1, pp 125-133, issn 0305-7453Article

Creatinine clearance as predictor of tobramycin elimination in adult patients with cystic fibrosisTOUW, D. J; VINKS, A. A. T. M. M; JACOBS, F et al.Therapeutic drug monitoring. 1996, Vol 18, Num 5, pp 562-569, issn 0163-4356Article

Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at homeVINKS, A. A. T. M. M; TOUW, D. J; HEIJERMAN, H. G. M et al.Therapeutic drug monitoring. 1994, Vol 16, Num 4, pp 341-348, issn 0163-4356Article

Suggestions for the optimization of the initial tobramycin dose in adolescent and adult patients with cystic fibrosisTOUW, D. J; VINKS, A. A. T. M. M; HEIJERMAN, H. G. M et al.Therapeutic drug monitoring. 1994, Vol 16, Num 2, pp 125-131, issn 0163-4356Article

Comment and counter-example to perturbation bounds for root-clustering of linear discrete-time systems'BAKKER, W; LUO, J. S.International journal of systems science. 1993, Vol 24, Num 11, pp 2205-2206, issn 0020-7721Article

Les complications du BCG intra-pleural en postopératoire dans le cancer broncho-pulmonaire = Postoperatoire intrapleural BCG complications in lung cancerBAKKER, W; NIJHUIS-HEDDES, J. M. A; DE LA RIVIERE, A. B et al.Médecine et hygiène. 1984, Num 1576, pp 2678-2681, issn 0025-6749, 3 p.Article

In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH valuesGAN, K.-H; GEUS, W. P; BAKKER, W et al.Alimentary pharmacology & therapeutics. 1996, Vol 10, Num 5, pp 771-775, issn 0269-2813Article

Quantitative assessment of pancreatic function by magnetic resonance in cystic fibrosisHEIJERMAN, H. G. M; TJON A THAM, R. T. O; BAKKER, W et al.Netherlands journal of medicine. 1993, Vol 43, Num 1-2, pp 59-63, issn 0300-2977Conference Paper

Omeprazole enhances the efficacy of pancreatin (pancreas) in cystic fibrosisHEIJERMAN, H. G; LAMERS, C. B; BAKKER, W et al.Annals of internal medicine. 1991, Vol 114, Num 3, pp 200-201, issn 0003-4819Article

Bronchioloalveolar carcinoma presenting as a thin walled cavity in a young manDE JONG, P. M; BUSSCHER, D. L. T; BAKKER, W et al.Thorax. 1989, Vol 44, Num 3, pp 230-231, issn 0040-6376Article

A long term scintigraphic bone abnormality after trauma: a pitfall in the survey for metastatic diseaseWONDERGEM, J. H. M; HOLSCHER, H. C; ARNDT, J. W et al.European journal of nuclear medicine. 1987, Vol 13, Num 6, pp 321-323, issn 0340-6997Article

Post-operative intrapleural BCG in lung cancer: a 5-year follow-up reportBAKKER, W; NIJHUIS-HEDDES, J. M. A; VAN DER VELDE, E. A et al.Cancer immunology and immunotherapy. 1986, Vol 22, Num 2, pp 155-159, issn 0340-7004Article

Vindesine, cisplatin, and bleomycin combination chemotherapy in non-small cell lung cancer: survival and quality of lifeBAKKER, W; VAN OOSTEROM, A. T; AARONSON, N. K et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 8, pp 963-970, issn 0277-5379Article

Crack growth monitoring on industrial plant using established electrical resistance 'scanner' technologyFARRELL, D. M; ROBBINS, B. J; STALLINGS, J et al.Insight (Northampton). 2008, Vol 50, Num 12, pp 690-694, issn 1354-2575, 5 p.Conference Paper

Spatial scale variations in vegetation indices and above-ground biomass estimates : implications for MERISVAN DER MEER, F; BAKKER, W; SCHOLTE, K et al.International journal of remote sensing (Print). 2001, Vol 22, Num 17, pp 3381-3396, issn 0143-1161Article

Simulation of MERIS data: potentials and limitations for mapping (soil) mineralogyVAN DER MEER, F; BAKKER, W; SCHOLTE, K et al.ITC journal. 1999, Vol 1, Num 3/4, pp 196-204, issn 0303-2434Article

Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosisTOUW, D. J; VINKS, A. A. T. M. M; HEIJERMAN, H. G. M et al.Therapeutic drug monitoring. 1996, Vol 18, Num 2, pp 118-123, issn 0163-4356Article

A cystic fibrosis mutation associated with mild lung diseaseKING-HAN GAN; VEEZE, H. J; VAN DEN OUWELAND, A. M. W et al.The New England journal of medicine. 1995, Vol 333, Num 2, pp 95-99, issn 0028-4793Article